Cart
sales@molnova.com
6-hydroxydihydrocinchonidine
CAS No. 5962-19-6
6-hydroxydihydrocinchonidine( —— )
Catalog No. M36942 CAS No. 5962-19-6
6'-hydroxydihydrocinchonidine is a metabolite of quinine, with antimicrobial and antitumor activity, and inhibitory effect on Trypanosoma brucei and Streptococcus pneumoniae.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 245 | In Stock |
|
| 10MG | 363 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 786 | In Stock |
|
| 100MG | 1088 | In Stock |
|
| 200MG | 1460 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6-hydroxydihydrocinchonidine
-
NoteResearch use only, not for human use.
-
Brief Description6'-hydroxydihydrocinchonidine is a metabolite of quinine, with antimicrobial and antitumor activity, and inhibitory effect on Trypanosoma brucei and Streptococcus pneumoniae.
-
Description6'-hydroxydihydrocinchonidine is a metabolite of quinine, with antimicrobial and antitumor activity, and inhibitory effect on Trypanosoma brucei and Streptococcus pneumoniae.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorDrug Metabolite | Antibiotic
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5962-19-6
-
Formula Weight312.41
-
Molecular FormulaC19H24N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](O)([C@]1([N@@]2C[C@H](CC)[C@](C1)(CC2)[H])[H])C=3C4=C(N=CC3)C=CC(O)=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Bepranemab
Bepranemab (UCB 0107), a humanized full-length IgG4 monoclonal antibody, targets the central tau epitope (amino acids 235-250) and is utilized in Alzheimer’s disease (AD) research .
-
(S)-(+)-2-Octanol
(S)-(+)-2-Octanol is the S-enantiomer of octan-2-ol. Octan-2-ol is involved in the production of nanomaterials and liquid crystal materials.
-
AC-261066
AC-261066 is a retinoic acid beta2 (beta2) receptor agonist (pEC50: 8.0).
